EE90 Cost-Effectiveness Analysis of Tumor Treating Fields in the Treatment of Newly Diagnosed Glioblastoma Based on Real-World Data

Glioblastoma (GBM) is the most aggressive and common primary brain malignancy. TTFields, a novel therapy that can be added to chemotherapy for the treatment of GBM, has proven efficacy in GBM treatment. At present, the evidence on health economics evaluation of TTFields therapy is limited. The objective of the study is to evaluate the cost-effectiveness of TTFields+TMZ compared with TMZ in newly-diagnosed GBM patients and provide economic evidence as a framework for policy and decision making in GBM treatment from Chinese context.